bioAffinity Technologies, Inc. (BIAF) Misses Q3 EPS by 465c

bioAffinity Technologies, Inc. (NASDAQ: BIAF) reported Q3 EPS of ($4.74), $4.65 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.45 million versus the consensus estimate of $1.55 million.

For earnings history and earnings-related data on bioAffinity Technologies, Inc. (BIAF) click here.

You May Also Be Interested In

• S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
• ICICI Securities Starts Amagi Media Labs (AMAGI:IN) at Buy (1)
• General Dynamics wins $249m in US military contracts